{"id":309458,"date":"2019-12-11T20:50:53","date_gmt":"2019-12-12T04:50:53","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/12\/healthcare-roundup-assembly-biosciences-readies-equity-offering-gilead-files-u-s-application\/"},"modified":"2019-12-11T20:51:14","modified_gmt":"2019-12-12T04:51:14","slug":"%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be-assembly-biosciences-%e5%87%86%e5%a4%87%e5%8f%91%e8%a1%8c%e8%82%a1%e7%a5%a8%e5%90%89%e5%88%a9%e5%be%b7%e6%8f%90%e4%ba%a4%e4%ba%86%e7%be%8e%e5%9b%bd","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/12\/%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be-assembly-biosciences-%e5%87%86%e5%a4%87%e5%8f%91%e8%a1%8c%e8%82%a1%e7%a5%a8%e5%90%89%e5%88%a9%e5%be%b7%e6%8f%90%e4%ba%a4%e4%ba%86%e7%be%8e%e5%9b%bd\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u7cbe\u9009\u2014\u2014Assembly Biosciences\u51c6\u5907\u53d1\u884c\u80a1\u7968\uff0c\u5409\u5229\u5fb7\u63d0\u4ea4\u4e86\u7f8e\u56fd\u7533\u8bf7"},"content":{"rendered":"<h2>Assembly Biosciences\u51c6\u5907\u53d1\u884c\u80a1\u7968<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=ASMB\">Assembly Biosciences\uff08NASDAQ\uff1aASMB\uff09<\/a>\u516c\u5f00\u53d1\u884c\u666e\u901a\u80a1\u3002\u4ef7\u683c\u3001\u6570\u91cf\u548c\u6761\u6b3e\u5c1a\u672a\u516c\u5e03\u3002\u76d8\u540e\u80a1\u4ef7\u4e0b\u8dcc4%\u3002<\/p>\n<h2>\u5409\u5229\u5fb7\u63d0\u4ea4CAR T\u6cbb\u7597\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u7533\u8bf7<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=GILD\">\u5409\u5229\u5fb7\u79d1\u5b66\uff08\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aGILD\uff09<\/a>\u7684\u5b50\u516c\u53f8Kite\u5df2\u5411FDA\u63d0\u4ea4\u4e86\u8425\u9500\u7533\u8bf7\uff0c\u4ee5\u5bfb\u6c42\u6279\u51c6CAR T\u7597\u6cd5KTE-X19\u7528\u4e8e\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\uff08\u4e00\u79cd\u7f13\u6162\u751f\u957f\u7684NHL\uff09\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u8ba1\u5212\u5728\u4e0b\u4e2a\u5b63\u5ea6\u5728\u6b27\u6d32\u63d0\u51fa\u7533\u8bf7\u3002<\/p>\n<h2>Endonovo Therapeutics\u5ba3\u5e03\u53cd\u5411\u80a1\u7968\u5206\u62c6<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=ENDV\">Endonovo Therapeutics\uff08OTCQB\uff1aENDV-33.3%\uff09<\/a>\u5ba3\u5e03\u5df2\u51b3\u5b9a\u5bf9\u516c\u53f8\u5df2\u53d1\u884c\u666e\u901a\u80a1\u8fdb\u884c\u53cd\u5411\u62c6\u5206\u3002\u8fd9\u5c06\u4f7f\u516c\u53f8\u666e\u901a\u80a1\u7684\u6d41\u901a\u80a1\u6570\u91cf\u51cf\u5c11\u5230\u7ea6100,530\u80a1\u3002<\/p>\n<h2>\u8bfa\u534e\u4e0eForendo Pharma\u5408\u4f5c\u6cbb\u7597\u809d\u810f\u75be\u75c5<\/h2>\n<p>\u8bfa\u534e\uff08-0.1%\uff09\u4e0e\u82ac\u5170Forendo Pharma\u8fbe\u6210\u4e00\u9879\u534f\u8bae\uff0c\u65e8\u5728\u53d1\u73b0\u7528\u4e8e\u6cbb\u7597\u6162\u6027\u809d\u75c5\u7684\u65b0\u836f\u3002<\/p>\n<p>\u6839\u636e\u4ea4\u6613\u6761\u6b3e\uff0cForendo\u5c06\u83b7\u5f97\u9884\u4ed8\u6b3e\u3001\u7814\u7a76\u7ecf\u8d39\u3001\u91cc\u7a0b\u7891\u548c\u51c0\u9500\u552e\u989d\u7684\u5206\u5c42\u7279\u8bb8\u6743\u4f7f\u7528\u8d39\uff0c\u4ee5\u53ca\u8bfa\u534e\u7684\u80a1\u6743\u3002\u7814\u7a76\u5408\u4f5c\u7ed3\u675f\u540e\uff0c\u8bfa\u534e\u5c06\u63a5\u7ba1\u6240\u6709\u5f00\u53d1\u3001\u5236\u9020\u548c\u5546\u4e1a\u5316\u6d3b\u52a8\u3002<\/p>\n<p>Forendo Pharma\u7684\u6838\u5fc3\u4e13\u957f\u662f\u4e00\u4e2a\u540d\u4e3aHSD17B\uff0817-\u03b2-\u7f9f\u57fa\u7c7b\u56fa\u9187\u8131\u6c22\u9176\uff09\u7684\u9176\u5bb6\u65cf\uff0c\u8be5\u9176\u5728\u8c03\u8282\u6fc0\u7d20\u4f5c\u7528\u4e2d\u8d77\u5173\u952e\u4f5c\u7528\u3002\u5b83\u7684\u4e3b\u8981\u9879\u76ee\u662f\u7528\u4e8e\u5b50\u5bab\u5185\u819c\u5f02\u4f4d\u75c7\u76841b\u671fHSD17B\u6291\u5236\u5242FOR-6219\u3002<\/p>\n<h2>\u542f\u52a8\u4e73\u817a\u764c\u6d4b\u8bd5\uff0cGenetic Tech\u4e0a\u6da822%<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=GENE\">Genetic Technologies Limited\uff08GENE + 21.6%\uff09<\/a>\u7684\u6210\u4ea4\u91cf\u589e\u957f\u4e86\u8fd15\u500d\uff0c\u8fd9\u662f\u7531\u4e8e\u8be5\u516c\u53f8\u4f5c\u51fa\u4e86\u7b2c\u4e09\u4ee3\u4e73\u817a\u764c\u6d4b\u8bd5\u5728\u4e0b\u4e2a\u5b63\u5ea6\u5f00\u59cb\u9500\u552e\u7684\u516c\u544a\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u7684\u76ee\u6807\u662f\u5efa\u7acb12\u4e2a\u4e34\u5e8a\u7ad9\u70b9\uff0c\u4ee5\u5c55\u793a\u5b9e\u7528\u6027\u3001\u7528\u6237\u4f53\u9a8c\u3001\u62a5\u9500\u548c\u5206\u914d\u3002\u8fd9\u9879\u88ab\u79f0\u4e3a\u201c\u4e73\u817a\u764c\u57fa\u56e0\u7c7b\u578b\u201d\u7684\u6d4b\u8bd5\u901a\u8fc7\u7ed3\u5408DNA\u548c\u4e73\u817aX\u7ebf\u6444\u5f71\u6570\u636e\u6765\u9884\u6d4b\u75be\u75c5\u98ce\u9669\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Assembly Biosciences readies equity offering; shares down 4% after hours. Gilead Sciences (NASDAQ:GILD) unit Kite has submitted a marketing application to the FDA seeking approval for CAR T therapy KTE-X19 for the treatment of adults with relapsed\/refractory mantle cell lymphoma, a type of slow-growing NHL.<\/p>\n","protected":false},"author":9,"featured_media":309443,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,455,925,459],"class_list":["post-309458","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-455","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/309458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=309458"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/309458\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/309443"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=309458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=309458"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=309458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}